Screener
eXoZymes, Inc. EXOZ Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -185.8%— | -132.6%— | —— | —— | —— | |
| Return on invested capital | -679.1%— | -520.5%-155pp | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 1.3×-5.2× | 2.5×-5.6× | 4.5×+4.3× | 6.2×— | 6.5×— | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.6× | 0.4×+0.2× | 0.3×— | 0.2×— | 0.1×— | |
| Per Share | ||||||
| Book value per share | $0.18-83.0% | $0.41-74.5% | $0.64+211% | $0.86+339% | $1.06+631% | |
| Valuation | ||||||
| Market capitalization | $69.84M-14.2% | $91.42M— | $121.01M— | $86.36M— | —— | |
| Price / book | 45.7×+34.5× | 26.9×— | 22.5×— | 11.9×— | —— |
FAQ
- Where do eXoZymes, Inc.'s ratios come from?
- Every ratio is computed from eXoZymes, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.